Novyra Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter ended on 30th September 2026

NOVYRA CIN NO. :- L21001GJ1987PLC171085 PHARMACHEM LIMITED GST NO : 24AAACE6640F120 October 23, 2026 BSE Limited Ground Floor, P.J. Tower Dalal Street Mumbai- 400001 Scrip Code: 519353 Sub: Intimation of Board Meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 2™ November, 2026 at the Registered Office of the Company inter alia to consider and approve the following: - 1. Unaudited financial result for the second quarter ended on 30" September, 2026 along with the Auditor's Limited Review Report. 2. Any other business with the permission of Chairman. Please take the same on your record and oblige. Thanking you, Yours faithfully, For Novyra Pharmachem Limited (Formerly known as Bansisons Tea Industries Limited) For, Novyra Pharmachem Limited Proit ™ Pravelify Director/Autho. Signatory Anilkumar Mohanbhai Amreliya Director DIN : 11339148 novyrapharmachemlimited@gmail.com & www.novyrapharmachemitd.com UD‘: +91 92654 53481 RS No. 432, T P Scheme No. 3, F P No. 89/A, City Survey No. 3763, Plot No. C, Palky Plot No. A, Ground Floor, Back Side, Pavthawala Compound, B/h Zenith Mill, Vasta Devdi Road, Surat- 395004, Gujarat, India